Magnitude Biosciences is a biotechnology firm combine experience in ageing research, the nematode C. elegans and automation.
Magnitude Biosciences has raised $951K in total funding. The most recent round was Seed. The last funding was announced in May 2025.
Magnitude Biosciences's investors include Northstar Ventures, Innovate UK, Finance Durham Fund, Future Fund, NPIF Maven Equity Finance.
Magnitude Biosciences is headquartered in Durham, United Kingdom.
Magnitude Biosciences is a biotechnology firm combine experience in ageing research, the nematode C. elegans and automation.
Magnitude Biosciences is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Magnitude Biosciences — Funding & Investors." VCBacked, May 27, 2025, https://www.vcbacked.co/company/magnitude-biosciences. Accessed July 20, 2026.
VCBacked. (2025). Magnitude Biosciences — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/magnitude-biosciences
{{cite web |title=Magnitude Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/magnitude-biosciences |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated